Understanding Immuno-Oncology Development and Opportunities

Maxime Bourgognon, PhD, PharmD, is an Oncology and Hematology Senior Analyst for GlobalData. Before joining GlobalData, he worked at the Institute of Pharmaceutical Science at King’s College London as a Research Assistant and PhD student. His research was based on designing and testing novel nanomedicines for targeting and treating cancer. Prior to this, he completed a Pharm.D. at the Faculty of Pharmaceutical Sciences in Toulouse, France. Maxime obtained his MSc in Pharmaceutical Biotechnology at the Faculty of Pharmaceutical Sciences of Montpellier in France, and developed pre-clinical research experience during an industrial internship at the Centre of Immunology of Pierre Fabre Laboratories. While obtaining his undergraduate degree, he was also involved in academic research projects at the Claudius Regaud Institute in Toulouse, France, and the Cambridge Research Institute in the UK.

Alice Stevens, Mbiol, is an Associate Analyst for GlobalData. Before joining GlobalData in 2016, Alice completed her Masters of Biology at Durham University. Her research focused on the post-translational modification, carbamylation, and its influence over the function and regulation of plant immune response protiens. Alice holds a first class degree in biological sciences from Durham University.

Fern Barkalow, PhD, is the Senior Director of Oncology and Hematology at GlobalData in Boston. Fern has over 20 years of experience in the biopharmaceutical industry, as well as a research background in molecular mechanisms of inflammation and metastasis. After leaving the lab bench, Fern then joined the database group at Incyte Pharmaceuticals where she helped develop the Proteome BioKnowledge Library, and led a cross-functional team tasked with creating databases covering diseases and molecular interactions. She then moved into the Medical Affairs group at Millennium Pharmaceuticals and managed medical writing projects involving clinical trials results for oncology drugs. Most recently, Fern was Associate Director of the Oncology team at Citeline, where she participated in developing and managing the Trialtrove database and interacted with clients through the research support service and custom analytics projects. Fern holds a PhD in Microbiology from The University of Medicine and Dentistry of New Jersey and was a postdoctoral fellow in Molecular Biology at Princeton University and in Pathology at Brigham and Women’s Hospital.